Jazz Pharmaceuticals (JAZZ) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.64 Bn | 12.79 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.54% |
| Dec 31, 2025 | -5.64% |
| Sep 30, 2025 | -12.32% |
| Jun 30, 2025 | -8.64% |
| Mar 31, 2025 | -21.56% |
| Dec 31, 2024 | -30.51% |
| Sep 30, 2024 | -22.77% |
| Jun 30, 2024 | -16.28% |
| Mar 31, 2024 | -21.40% |
| Dec 31, 2023 | -37.22% |
| Sep 30, 2023 | -21.76% |
| Jun 30, 2023 | -21.46% |
| Mar 31, 2023 | -20.85% |
| Dec 31, 2022 | -17.96% |
| Sep 30, 2022 | -13.15% |
| Jun 30, 2022 | -17.38% |
| Mar 31, 2022 | -3.82% |
| Dec 31, 2021 | -6.78% |
| Sep 30, 2021 | -9.54% |
| Jun 30, 2021 | 0.55% |
| Mar 31, 2021 | -16.43% |
| Dec 31, 2020 | -1.36% |
| Sep 30, 2020 | 5.77% |
| Jun 30, 2020 | 3.13% |
| Mar 31, 2020 | 2.16% |
| Dec 31, 2019 | 1.40% |
| Sep 30, 2019 | -6.70% |
| Jun 30, 2019 | -18.95% |
| Mar 31, 2019 | -19.12% |
| Dec 31, 2018 | 13.42% |
| Sep 30, 2018 | 3.24% |
| Jun 30, 2018 | 0.77% |
| Mar 31, 2018 | -0.12% |
| Dec 31, 2017 | 0.06% |
| Sep 30, 2017 | -18.98% |
| Jun 30, 2017 | -15.61% |
| Mar 31, 2017 | -10.75% |
| Dec 31, 2016 | -21.95% |
| Sep 30, 2016 | -30.32% |
| Jun 30, 2016 | -55.01% |
| Mar 31, 2016 | -72.04% |
| Dec 31, 2015 | -85.68% |
| Sep 30, 2015 | -112.87% |
| Jun 30, 2015 | -149.28% |